They focused on patients with both type 1 and type 2 diabetes with different treatment modalities (insulin pump, multiple daily insulin injections, oral hypoglycemic agents, GLP-1 agonists) and different glucose monitoring methods (CGM, FGM, SMBG) (Table 1 and Table 2). Here, INS is linked to type 2 diabetes mellitus.